BTIG cuts target for Intuitive Surgical stock to USD 454.00
Published on 10/13/2026 at 12:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- BTIG cut its Intuitive Surgical price target from USD 469.00 to USD 454.00 on October 12, 2026.
- Second-quarter 2026 revenue reached USD 2.89 billion, up 18.40 percent from the prior-year quarter.
- Intuitive Surgical stock was trading at EUR 383.08 at Lang & Schwarz on October 13, 2026 at 12:43 p.m. CEST.
- The company is scheduled to report third-quarter 2026 results on October 20, 2026.
BTIG cut its Intuitive Surgical target from USD 469.00 to USD 454.00 on October 12, 2026, while Intuitive Surgical stock was trading at EUR 383.08 at Lang & Schwarz at 12:43 p.m. CEST on October 13, 2026. The target reduction puts the latest analyst view below the previous USD 469.00 level, while the next earnings date is already set for October 20, 2026.
BTIG lowers its price target
According to Markets Insider on October 12, 2026, BTIG kept a Buy rating while lowering its target by USD 15.00, or 3.20 percent, from USD 469.00 to USD 454.00. The report framed the change as part of a broader preview of the medical technology earnings season.
The arithmetic matters: a USD 454.00 target is 3.20 percent below the former USD 469.00 target. That adjustment creates a more cautious near-term valuation reference ahead of Intuitive Surgical's third-quarter report.
Revenue growth sets the earnings bar
For the quarter ending June 30, 2026, Intuitive Surgical reported revenue of USD 2.89 billion and net profit of USD 818.1 million. Markets Insider said the comparable prior-year quarter produced revenue of USD 2.44 billion and net profit of USD 658.4 million.
Revenue therefore increased 18.44 percent year over year, while net profit rose 24.22 percent on the figures cited for the two quarters. The operating backdrop remains numerically stronger than the revised BTIG target suggests, but the two measures address different periods and questions.
Three dated signals for the stock
On July 16, 2026, Intuitive Surgical reported second-quarter revenue of USD 2.89 billion. On September 8, 2026, the company highlighted a meta-analysis covering 13 benign conditions in a release on its investor site. On October 12, 2026, BTIG lowered its target from USD 469.00 to USD 454.00 while retaining its Buy rating.
What comes next for Intuitive Surgical?
MarketBeat lists October 20, 2026 as the projected third-quarter reporting date and cites consensus estimates of USD 2.65 earnings per share and USD 2.91 billion in revenue. Barron's lists January 26, 2027 for fiscal-year 2026 earnings.
Stock price and market value
Intuitive Surgical was trading at EUR 383.08 at Lang & Schwarz on October 13, 2026 at 12:43 p.m. CEST. The finance quote for the Nasdaq listing showed a market capitalization of USD 151.1 billion and a 52-week range of USD 328.57 to USD 603.88 as of October 12, 2026.
The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.
Intuitive Surgical stock facts
- Company: Intuitive Surgical, Inc.
- ISIN: US46120E6023
- Ticker: ISRG
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 13, 2026, 12:43 p.m. CEST): EUR 383.08
- Market capitalization: USD 151.1 billion (as of October 12, 2026)
- 52-week range: USD 328.57-603.88 (as of October 12, 2026)
- Sector / Industry: Health Care / Health Care Equipment and Supplies
- Index membership: Nasdaq-100
- Next earnings date: October 20, 2026
Market context: Market report Nasdaq Composite.
